Pr
Proteon (Charles River)
Utrecht NLFounded 200950 employees
Private CapbiotechAcquiredOncology
Platform: SPR Biosensors
Market Cap
N/A
All Drugs
3
Clinical Trials
5
Failed / Terminated
3
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Elracapivasertib | PRO-9417 | NDA/BLA | 1 | PARP | ALL | ||
| PRO-1192 | PRO-1192 | Phase 1 | 2 | GIP-R | FL | ||
| Motabrutinib | PRO-4487 | Preclinical | 2 | Aβ | UC |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (4)